Phase I study using Vidaza (5'-azacytidine) as a DNA methylation inhibitor in patients with chronic lymphocytic leukemia
Phase of Trial: Phase I
Latest Information Update: 02 Mar 2007
At a glance
- Drugs Azacitidine (Primary)
- Indications Chronic lymphocytic leukaemia
- Focus Pharmacodynamics
- 02 Mar 2007 New trial record.